News | April 14, 2025
Novartis to invest $23 billion on expansion of manufacturing and R&D facilities in US
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
This registration authorizes Nureca Technologies to continue manufacturing and exporting asuite of medical devices to the United States
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
Dr. Benjamin Bechem, already leading WeylChem Organica and European custom manufacturing sales
Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206 and BAT2506
The products will be manufactured in Goa India and marketed & distributed in Australian markets
Prior to joining Neuland, Deshmukh held several key positions at Cipla
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
403 entries from 22 states covering 168 districts highlight groundbreaking initiatives vital to improving national nutrition metrics.
Subscribe To Our Newsletter & Stay Updated
